Matinas BioPharma Holdings, Inc. Gains 22.15%
Fri, Oct 21, 2022 at 07:32 PM
Matinas BioPharma Holdings, Inc. (MTNB:NYSEMKT) soared at $0.85, a gain of 22.1%. On Fri, Oct 21, 2022, MTNB:NYSEMKT hit a New 2-Week High of $0.85. The stock appeared on our News Catalysts scanner on Fri, Oct 21, 2022 at 08:17 AM in the 'MISCELLANEOUS' category. From Fri, Oct 07, 2022, the stock recorded 50.00% Up Days and 54.55% Green Days
About Matinas BioPharma Holdings, Inc. (MTNB:NYSEMKT)
Matinas BioPharma Holdings Inc is a clinical-stage biopharmaceutical company engaged in identifying & developing safe and effective broad spectrum therapeutics for the treatment of serious and life-threatening infections.
Top 10 Gainers:
- Huadi International Group Co. Ltd. (HUDI:NASDAQ), 89.27%
- Altamira Therapeutics Ltd. (CYTO:NASDAQ), 58.64%
- Missfresh Limited (MF:NASDAQ), 57.5%
- Enservco Corporation (ENSV:NYSEMKT), 37.42%
- Renovare Environmental Inc. (RENO:NASDAQ), 33.33%
- Kaleyra Inc. (KLR:NYSE), 24.85%
- Veris Residential Inc. (VRE:NYSE), 23.27%
- Matinas BioPharma Holdings, Inc. (MTNB:NYSEMKT), 22.15%
- Candel Therapeutics Inc. (CADL:NASDAQ), 21.62%
- Energy Focus, Inc. (EFOI:NASDAQ), 21.47%